VMD 30283

Drug Profile

VMD 30283

Alternative Names: VMD30283

Latest Information Update: 21 Sep 2015

Price : $50

At a glance

  • Originator VM Discovery
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Myocardial infarction

Most Recent Events

  • 21 Sep 2015 No recent reports on development identified - Phase-I/II for Myocardial infarction in USA (unspecified route)
  • 21 Feb 2007 VMD 30283 is available for partnering or licensing worldwide (http://www.vmdiscovery.com/)
  • 21 Feb 2007 Phase-I/II clinical trials in Myocardial infarction in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top